Innovative Cancer Treatments Isoray's development of Cesium-131 brachytherapy seeds offers a breakthrough in cancer treatment, especially for prostate cancer patients, highlighting a significant opportunity to partner with leading medical centers seeking cutting-edge solutions.

Growing Market Adoption The increasing deployment of brachytherapy seeds in top hospitals and clinics across the U.S. indicates a rising demand for advanced radiation oncology products, presenting potential for expanding sales channels to healthcare providers.

Defense and Security Expansion EagleNXT’s successful sales of ISR drone solutions to U.S. military training centers showcase a burgeoning market in government and defense sectors for surveillance and ISR technology.

Uranium Mining Growth Recent operational start-ups and project expansions in U.S. uranium ISR projects, supported by strategic mineral rights acquisitions, create opportunities for suppliers and technology providers to supply equipment or services to the nuclear energy industry.

Funding and Market Opportunity With a revenue range of 1 to 10 million dollars backed by substantial funding of 21 million dollars, Isoray is positioned for growth and potential strategic partnerships in medical device manufacturing and distribution.